StemBioSys CEO: Company has room to grow in San Antonio

Bob Hutchens is CEO of StemBioSys Inc. CARLOS JAVIER SANCHEZ | SABJ By W. Scott Bailey – Senior ...

SA researchers exploring use of re-purposed cancer drugs to combat deadly TB

Texas Biomedical Research Institute President and CEO Dr. Larry Schlesinger, right, with Eusondia Arnett, ...


April 11, 2016

When: 7:00 am – 8:00 pm Monday, April 11

Where: Texas Medical Center Accelerator (TMCx), 2450 Holcombe Blvd, Suite X, Houston, TX 77021

The RESI conference will bring together hundreds of senior level executives, corporate strategics, and emerging biotech, med tech and digital health companies to discuss fundraising opportunities for early stage companies. RESI focuses on 10 categories of early stage investors. Through an expansive series of panels and workshops, investors explain their current investment mandates and process of identifying and qualifying candidates. The RESI Partnering Forum, employs a sourcing platform that fundraising CEOs use to identify life science investors who fit their technology sector and stage of development.

To register:!tmcx-2016/sl0v1



Stay informed. Subscribe to BioMed SA news alerts.